The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on January 12, 2026

Jan. 12, 2026

Space Force Association Announces 2025 Spacepower Excellence Awards Recipients

EIN Presswire

Jan. 12, 2026

GWM Unveils Global Technology Investment White Paper at CES 2026, Anchoring 'User Value' as the Core of Innovation

EIN Presswire

Jan. 12, 2026

Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 12, 2026

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 12, 2026

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 12, 2026

Brunswick Announces Inferred Mineral Resource of 52.2 Mt Grading 1.08% Li2O on Globex’s 3% GMR Royalty Claims

GlobeNewswire

Jan. 12, 2026

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 12, 2026

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

GlobeNewswire

Jan. 12, 2026

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

GlobeNewswire

Jan. 12, 2026

Latin Metals Positions for a Catalyst-Driven 2026 with Gold and Copper Exposure

GlobeNewswire

Jan. 12, 2026

Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)

GlobeNewswire

Jan. 12, 2026

CRITICAL METALS CORP NASDAQ-CRML Acquires an Integrated Rare Earth Element Assay Analysis Lab Facility to Support Faster Drilling Assay Results for 2026 Drilling Campaign at Tanbreez

GlobeNewswire

Jan. 12, 2026

Integral Metals Provides 2025 Year-in-Review and Outlines 2026 Exploration Plans

GlobeNewswire

Jan. 12, 2026

Cabaletta Bio Announces 2026 Strategic Priorities

GlobeNewswire

Jan. 12, 2026

Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio

GlobeNewswire

Jan. 12, 2026

Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 12, 2026

Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones

GlobeNewswire

Jan. 12, 2026

Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress

GlobeNewswire

Jan. 12, 2026

Mereo BioPharma Provides Corporate Update

GlobeNewswire

Jan. 12, 2026

Copper Quest and i2i Enter Into Corporate Marketing and Investor Awareness Agreement

GlobeNewswire